Joshua Hexter Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

Joshua Hexter is COO & CBO of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 833,167 shares of ORMP, which is worth approximately $1.74 Million. The most recent transaction as insider was on Feb 11, 2025, when has been sold 126,834 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 833K

62.78% 3M change

72.92% 12M change

Total Value Held $1.74 Million

Joshua Hexter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2025	BUY Grant, award, or other acquisition	-	126,834 Added 13.21%	833,167 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	194,500 Added 21.59%	706,333 Common Stock
Nov 07 2024	BUY Grant, award, or other acquisition	-	30,000 Added 5.54%	511,833 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	180,500 Added 27.25%	481,833 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	27,000 Added 8.22%	301,333 Common Stock
Apr 17 2023	BUY Grant, award, or other acquisition	-	108,000 Added 28.25%	274,333 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	42,000 Added 20.16%	166,333 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	21,000 Added 14.45%	124,333 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	-	33,333 Added 24.39%	103,333 Common Stock

Joshua Hexter

COO & CBO

Jerusalem, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Value

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP

Account